NICE recommends once-weekly injection for severe blood clotting disorder Efanesoctocog alfa, a once-weekly treatment for patients with severe haemophilia A, removes the need for frequent dosing, owing to its effective bleeding control.…
Fewer than 20% of type 2 diabetes patients on most effective medicine for them, model shows The model was also associated with a 38% reduction in the likelihood of glycaemic failure over five years.…
Tips for building an inclusive pharmacy workforce The Inclusive Pharmacy Practice (IPP) initiative was created as a means of co-ordinating the pharmacy profession’s response to the ongoing need to improve inclusivity. This article outlines practical steps pharmacy teams can take to implement the IPP agenda within their workplace.…
MPs call for urgent review into medicines shortages A letter from 45 cross-party MPs has urged the government to look into medicines shortages to ensure patients have their “life-saving medications”.…
Government ‘a long way off’ from meeting targets to control AMR infections Despite the government’s goal of reducing antimicrobial-resistant infections by 10% between 2018 and 2025, a National Audit Office report found that infections in England had risen by 2023 to 13% above the 2018 baseline.…
Testosterone in menopause: a review of the evidence and prescribing practice A closer look at the evidence base around testosterone prescribing for women with menopause, analysing the impact of regional formularies and the surge in demand in recent years.…
Almost 400,000 patients unable to get prescriptions from their local pharmacy, analysis reveals The Liberal Democrats have urged the government to take steps to address cost increases that are affecting medicines access and struggling pharmacies.…
Community Pharmacy England seeks clarity on proposals to regulate NHS managers The negotiator said it wants confirmation that community pharmacies do not fall under the proposals, as they are not NHS organisations and are already regulated.…
Nine in ten people would accept a pharmacogenomics test, reveals survey The majority of respondents to a survey said they would be motivated to take a pharmacogenomics test to enhance drug effectiveness and reduce the risk of adverse drug reactions.…
First non-cannabis treatment for rare form of epilepsy made available on NHS Fenfluramine is a non-cannabis treatment for patients with Lennox-Gastaut syndrome who do not respond to existing treatments or clobazam owing to its side effects.…
